These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 2405109)

  • 21. [M-VAC (methotrexate, vinblastine, adriamycin and cisplatin) chemotherapy in advanced renal pelvic and ureteral carcinoma].
    Igawa M; Ueki T; Ueda M; Okada K; Usui T; Ohnishi Y; Kume T; Masu C; Ishino T; Nakatsu H
    Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 1):2577-82. PubMed ID: 2673046
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A phase II trial of cisplatin, methotrexate, levofolinic acid, and 5-fluorouracil in the treatment of patients with locally advanced, metastatic squamous cell carcinoma of the head and neck.
    Caponigro F; Comella P; Marcolin P; Russo Spena F; Biglietto M; Cartenì G; De Lucia L; Avallone A; Gravina A; Comella G
    Cancer; 1999 Feb; 85(4):952-9. PubMed ID: 10091775
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Squamous cell carcinoma and basal cell carcinoma].
    Suzuki T; Inoue Y; Kuramochi A; Kiyohara Y; Ikeda S
    Gan To Kagaku Ryoho; 1997 Jan; 24(1):16-22. PubMed ID: 9020940
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cisplatin and 5-fluorouracil for advanced locoregional and metastatic squamous cell carcinoma of the skin.
    Khansur T; Kennedy A
    Cancer; 1991 Apr; 67(8):2030-2. PubMed ID: 2004320
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analysis of efficacy and toxicity of chemotherapy with cisplatin, 5-fluorouracil, methotrexate and leucovorin (PFML) and radiotherapy in the treatment of locally advanced squamous cell carcinoma of the head and neck.
    Katori H; Tsukuda M; Taguchi T
    Cancer Chemother Pharmacol; 2007 May; 59(6):789-94. PubMed ID: 17053926
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term results of a phase II trial of induction chemotherapy with uracil-ftegafur (UFT), vinorelbine, and cisplatin (UFTVP) followed by radiotherapy concomitant with UFT and carboplatin (RT/UFTJ) in a primary site preservation setting for resectable locally advanced squamous cell carcinoma of larynx and hypopharynx.
    Rivera F; Vega-Villegas ME; López-Brea MF; García-Castaño A; de Juan A; Collado A; Galdós P; Rubio A; del Valle A; Rama J; Sanz-Ortiz J
    Laryngoscope; 2004 Jul; 114(7):1163-9. PubMed ID: 15235341
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multicenter phase I-II trial of docetaxel, cisplatin, and fluorouracil induction chemotherapy for patients with locally advanced squamous cell cancer of the head and neck.
    Posner MR; Glisson B; Frenette G; Al-Sarraf M; Colevas AD; Norris CM; Seroskie JD; Shin DM; Olivares R; Garay CA
    J Clin Oncol; 2001 Feb; 19(4):1096-104. PubMed ID: 11181674
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Induction chemotherapy with docetaxel and cisplatin is highly effective for locally advanced nasopharyngeal carcinoma.
    Ekenel M; Keskin S; Basaran M; Ozdemir C; Meral R; Altun M; Aslan I; Bavbek SE
    Oral Oncol; 2011 Jul; 47(7):660-4. PubMed ID: 21596616
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Combined CDDP-THP-PEP chemotherapy (PTP therapy) for head and neck squamous cell carcinoma--a group study].
    Sugasawa M; Nibu K; Ichimura K; Kaga K; Asai M; Senba T; Yamasoba T; Tsunoda K; Abe K; Kobayashi T
    Gan To Kagaku Ryoho; 1994 Jun; 21(7):969-74. PubMed ID: 8002635
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pilot study on induction chemotherapy with cisplatin, epirubicin, etoposide and bleomycin in cervical cancer stage Ib, IIa and IIb.
    Panetta A; Angelelli B; Martoni A
    Anticancer Res; 1999; 19(1B):765-8. PubMed ID: 10216490
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effective radiochemotherapy with cisplatin and etoposide for the management of patients with locally inoperable and metastatic esophageal carcinoma.
    Hejna M; Kornek GV; Schratter-Sehn AU; Zach M; Schoder M; Raderer M; Rosen H; Schiessel R; Scheithauer W
    Cancer; 1996 Oct; 78(8):1646-50. PubMed ID: 8859175
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phase III study comparing cisplatin plus fluorouracil to paclitaxel, cisplatin, and fluorouracil induction chemotherapy followed by chemoradiotherapy in locally advanced head and neck cancer.
    Hitt R; López-Pousa A; Martínez-Trufero J; Escrig V; Carles J; Rizo A; Isla D; Vega ME; Martí JL; Lobo F; Pastor P; Valentí V; Belón J; Sánchez MA; Chaib C; Pallarés C; Antón A; Cervantes A; Paz-Ares L; Cortés-Funes H
    J Clin Oncol; 2005 Dec; 23(34):8636-45. PubMed ID: 16275937
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Surgical treatment of stage III lung cancer after chemotherapy and radiotherapy.
    Lee DY; Kim HK; Paik HC; Kim HJ; Kim SJ
    Jpn J Clin Oncol; 1994 Apr; 24(2):101-5. PubMed ID: 8158856
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chemotherapy of basal cell and squamous cell carcinoma of the eyelids and periorbital tissues.
    Luxenberg MN; Guthrie TH
    Ophthalmology; 1986 Apr; 93(4):504-10. PubMed ID: 3703526
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of low dose cisplatin plus 5-fluorouracil for treatment of recurrent and/or advanced squamous cell carcinoma of the head and neck.
    Kohno N; Kitahara S; Tamura E; Tanabe T; Nakanoboh M; Kawada M; Shirasaka T
    Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():592-9. PubMed ID: 10895216
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Chemotherapy and multimodality therapy in the treatment of esophageal cancer].
    Ando N; Ozawa S; Kitajima M; Iizuka T
    Gan To Kagaku Ryoho; 1995 Jun; 22(7):869-76. PubMed ID: 7540823
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oral vinorelbine and cisplatin with concurrent radiotherapy after induction chemotherapy with cisplatin and docetaxel for patients with locally advanced non-small cell lung cancer: the GFPC 05-03 study.
    Descourt R; Vergnenegre A; Barlesi F; Lena H; Fournel P; Falchero L; Berard H; Hureaux J; Le Caer H; Chavaillon JM; Geriniere L; Monnet I; Chouabe S; Robinet G;
    J Thorac Oncol; 2011 Feb; 6(2):351-7. PubMed ID: 21164367
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cisplatin/etoposide versus ifosfamide/etoposide combination chemotherapy in small-cell lung cancer: a multicenter German randomized trial.
    Wolf M; Havemann K; Holle R; Gropp C; Drings P; Hans K; Schroeder M; Heim M; Dommes M; Mende S
    J Clin Oncol; 1987 Dec; 5(12):1880-9. PubMed ID: 2824710
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effectiveness of pharmacokinetic modulating chemotherapy combined with cisplatin as induction chemotherapy in resectable locally advanced head and neck cancer: phase II study.
    Chang PM; Chen PM; Chu PY; Wang LW; Tai SK; Tsai TL; Huang JL; Wang YF; Chang SY; Yang MH
    Cancer Chemother Pharmacol; 2008 Dec; 63(1):9-17. PubMed ID: 18343925
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High-dose cisplatin combination chemotherapy in the treatment of advanced epithelial ovarian carcinoma.
    Hainsworth JD; Burnett LS; Jones HW; Grosh WW; Johnson DH; Greco FA
    J Clin Oncol; 1990 Mar; 8(3):502-8. PubMed ID: 2407811
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.